YOYuanming Ouyang

Yuanming Ouyang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yuanming Ouyang has a total of 115 co-authors. Here are the top co-authors by number of shared publications:

  • Weien Yuan

    Shanghai Frontiers Science Center of Drug Target Identification and Delivery School of Pharmaceutical Sciences Shanghai Jiao Tong University Shanghai 200240 China

    15 shared publications
  • Cunyi Fan

    Department of Orthopedics, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China

    14 shared publications
  • Yun Qian

    National Center for Orthopaedics, Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

    12 shared publications
  • Jialin Song

    Department of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

    6 shared publications
  • Xiaotian Zhao

    School of Pharmacy Shanghai Jiao Tong University No. 800 Dongchuan Road Shanghai 200240 China

    5 shared publications
  • Huiquan Jiang

    Department of Orthopedics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China

    4 shared publications

Latest Publications

  • Open Access

    Size-Engineered Porous β-TCP Microspheres Fabricated by a Photopolymerization-Assisted Oil-Phase Method and Their Size-Dependent Osteogenic Performance

    by Yide Zhang, Jianxi Lu, Xiao Lu, PeiChun Hsu, Yuanming Ouyang

    Porous β-tricalcium phosphate (β-TCP) microspheres are promising injectable biomaterials for bone regeneration, yet conventional fabrication methods often suffer from poor size uniformity, limited porosity, and insufficient control over biological responses. In this study, a photopolymerization-assisted oil-phase method was developed to fabricate β-TCP microspheres with highly uniform spherical morphology and precisely controlled diameters of 100, 150, and 200 μm. The combination of UV-induced rapid solidification and oil-phase droplet templating enabled the formation of interconnected microporosity, with total porosity ranging from 44% to 51% and specific surface areas between 0.26 and 0.70 m²/g. Systematic physicochemical characterization and in vitro assays were conducted to establish the size-dependent structure–property–bioactivity relationships. Microspheres of smaller size showed faster Ca²⁺ release because of their larger specific surface area, and all groups showed minimal weight loss within 21 days, indicating that the microspheres were stable in physiological environments. The MC3T3-E1 pre-osteoblasts showed good adhesion and viability on the surface of the microspheres. The cells also showed good proliferation and spreading on the microspheres, which suggests that the microspheres were cytocompatible. Among the three groups, MC3T3-E1 cells cultured on 150 μm-sized microspheres which have optimal surface curvature and ion release capacity exhibited a significantly higher ALP activity, OCN, Runx2 expression, and calcium content than cells cultured on 100 or 200 μm-sized microspheres. Therefore, this method may also provide guidelines to design injectable bone graft substitutes for engineering bone tissue.


  • Open Access

    Machine Learning Prediction of Poor Flexion-Extension Outcome After Open Elbow Arthrolysis: Identifying Individual Predisposition Using Clinical and Laboratory Indicators

    by Xinyu Wang, Wencai Liu, Yuanhao Tong, Yaowei Lv, Limin Han, Cunyi Fan, Yuanming Ouyang

    Background: Elbow stiffness is a condition that causes mobility dysfunction and severe suffering in patients. Patients with posttraumatic elbow stiffness who undergo open elbow arthrolysis are at risk for poor postoperative flexion-extension outcome, which leads us to suspect that these patients possess a unique “elbow stiffness predisposition.” Purpose: To develop an innovative predictive model that combines clinical and laboratory indicators to forecast poor flexion-extension outcomes after open elbow arthrolysis, thereby interpreting the “elbow stiffness predisposition.” Study Design: Cohort study; Level of evidence, 3. Methods: Patients who underwent open elbow arthrolysis between 2019 and 2022 were selected for model training and validation (n = 254), while those who underwent open elbow arthrolysis between 2016 and 2017 served as a test set (n = 35). The study assessed 19 clinical features and 58 laboratory parameters. A comparative analysis of several machine learning models—logistic regression, Naive Bayes, decision trees, random forest, gradient boosting, and XGBoost—was performed to identify the most effective approach. SHapley Additive exPlanations (SHAP) were employed to prioritize the key factors. Results: Using univariate analysis and the least absolute shrinkage and selection operator (LASSO) regression, 14 key variables were selected for inclusion in the model. The XGBoost model demonstrated superior performance, reaching an area under the curve of 0.909 on the test dataset. The most important indicator identified by LASSO was alkaline phosphatase. Indicators ranked by SHAP were lipoprotein(a), alkaline phosphatase, visual analog scale score, serum calcium, basophil count, serum sodium, previous arthrolysis, alanine aminotransferase, blood glucose, preoperative elbow range of motion, Cystatin C, uric acid, tobacco use, and serum cholinesterase. Conclusion: We have successfully developed a machine learning model using 14 key indicators to predict poor flexion-extension outcomes, which preliminarily explains the “elbow stiffness predisposition.”

  • Open Access

    Open elbow arthrolysis with hinged external fixation for postburn elbow stiffness: a case series with an averaged 4-year follow-up

    by Yuanhao Tong, Yaowei Lv, Xinyu Wang, Cunyi Fan, Yuanming Ouyang

    Patients with severe burns may develop heterotopic ossification (HO), articular cartilage loss, and soft tissue contracture in the elbow, significantly limiting elbow function and diminishing quality of life. Open elbow arthrolysis (OEA) combined with hinged external fixation (HEF) has demonstrated efficacy in managing severe elbow stiffness. However, no recent studies have specifically investigated its application in postburn elbow stiffness. This study evaluates the clinical outcomes of OEA with HEF in patients with postburn elbow stiffness, with an average follow-up period of four years. This study included patients with postburn elbow stiffness treated between May 2018 and December 2021. Eleven participants underwent OEA combined with HEF and were followed up for an average of 50.7 months (range: 37–62 months). Pre- and postoperative data, including elbow and forearm mobility, functional improvements, radiographic results, and complications, were systematically collected and analysed. Substantial improvements were observed in elbow and forearm mobility, with preoperative flexion-extension arc increasing from 14° to 77° and forearm rotation improving from 83° to 105° at the final follow-up (P < 0.001). Disabilities of the Arm, Shoulder, and Hand questionnaire (DASH) score and the Mayo Elbow Performance Index (MEPI) significantly improved (P < 0.001). Pain levels notably decreased (P < 0.001). Postoperative complications include transient ulnar nerve symptoms in 2 patients, pain in 3 patients, and 1 HO recurrence. Burn-related elbow stiffness patients treated with OEA and HEF showed encouraging clinical results, marked by notable enhancements in elbow movement and functionality. The results proved the technique effective for elbow stiffness after burn injury. Level IV, Case Series, Treatment Study.


  • Open Access

    Fast shaping, biodegradation and microenvironment modulation in bioceramic calcium phosphate cement enhances osteointegration and bone regeneration

    by Yukai Yin, Xiao Lu, Yumeng Xie, Shiyong Lin, Jin He, Yuanming Ouyang

    Critical bone defects require repair materials for optimal treatment. The current range of available materials has limitations, including donor availability, rejection, disease transmission, and inadequate filling. Calcium phosphate bone cement (CPC) is a bone repair material, but most CPCs on the market have two drawbacks: difficulty degrading and prolonged solidification time. The purpose of this study was to develop a CPC that is rapidly moldable and biodegradable, improves the acid‒base microenvironment, and is more suitable for clinical use. This CPC was prepared from β-tricalcium phosphate bioceramics (TCP) and calcium phosphate monohydrate and is designated a bioceramic CPC (BCPC). TCP was used as a control to determine the biocompatibility of BCPC and its impact on osteogenesis-related protein activity. The BCPC and TCP implants were placed in the femurs of rabbits, and x-ray/micro-CT images were obtained at weeks 4, 8, and 12 postoperatively. Additionally, samples from the three time points were stained and analyzed for their osteogenic and degradation properties. BCPC submerged in phosphate buffer reached a neutral pH of 6.98 ± 0.02 on Day 3. In vitro tests revealed that BCPC increased alkaline phosphatase and osteopontin activities in MC3T3-E1 cells. The x-ray and micro-CT results revealed that BCPC degraded while the TCP volume remained stable. Micro-CT revealed that BCPC degraded by 26.93% and formed 12.89% new bone by week 12. The histological results showed that BCPC had good biocompatibility and osteointegration ability. BCPC is characterized by rapid solidification and molding and good biocompatibility, and its degradation rate matches the rate of bone regeneration. BCPC could rapidly improve the surrounding pH, providing the foundation for its clinical application.


  • Uni-directional release of ibuprofen from an asymmetric fibrous membrane enables effective peritendinous anti-adhesion

    by Jixia Deng, Zhixiao Yao, Shikun Wang, Xinyu Zhang, Lei Zhan, Tongyu Wang, Wenhua Yu, Jiamei Zeng, Jinglei Wu, Shaoju Fu, et al.


  • Open Access

    Chiral MoS2@BC fibrous membranes selectively promote peripheral nerve regeneration

    by Mengru Li, Xiao Li, Yaowei Lv, Hede Yan, Xiang-Yang Wang, Jin He, Chao Zhou, Yuanming Ouyang

    Background: Molybdenum disulfide (MoS2) has excellent physical and chemical properties. Further, chiral MoS2 (CMS) exhibits excellent chiroptical and enantioselective effects, and the enantioselective properties of CMS have been studied for the treatment of neurodegenerative diseases. Intriguingly, left- and right-handed materials have different effects on promoting the differentiation of neural stem cells into neurons. However, the effect of the enantioselectivity of chiral materials on peripheral nerve regeneration remains unclear. Methods: In this study, CMS@bacterial cellulose (BC) scaffolds were fabricated using a hydrothermal approach. The CMS@BC films synthesized with L-2-amino-3-phenyl-1-propanol was defined as L-CMS. The CMS@BC films synthesized with D-2-amino-3-phenyl-1-propanol was defined as D-CMS. The biocompatibility of CMS@BC scaffolds and their effect on Schwann cells (SCs) were validated by cellular experiments. In addition, these scaffolds were implanted in rat sciatic nerve defect sites for three months. Results: These chiral scaffolds displayed high hydrophilicity, good mechanical properties, and low cytotoxicity. Further, we found that the L-CMS scaffolds were superior to the D-CMS scaffolds in promoting SCs proliferation. After three months, the scaffolds showed good biocompatibility in vivo, and the nerve conducting velocities of the L-CMS and D-CMS scaffolds were 51.2 m/s and 26.8 m/s, respectively. The L-CMS scaffolds showed a better regenerative effect than the D-CMS scaffolds. Similarly, the sciatic nerve function index and effects on the motor and electrophysiological functions were higher for the L-CMS scaffolds than the D-CMS scaffolds. Finally, the axon diameter and myelin sheath thickness of the regenerated nerves were improved in the L-CMS group. Conclusion: We found that the CMS@BC can promote peripheral nerve regeneration, and in general, the L-CMS group exhibited superior repair performance. Overall, the findings of this study reveal that CMS@BC can be used as a chiral nanomaterial nerve scaffold for peripheral nerve repair. Graphical


  • Open Access

    Chiral MoS2 @BC fibrous membranes selectively promote peripheral nerve regeneration

    by Mengru Li, Xiao Li, Yaowei Lv, Hede Yan, Xiang-Yang Wang, Jin He, Chao Zhou, Yuanming Ouyang

    Background Molybdenum disulfide (MoS2) has excellent physical and chemical properties. Further, chiral MoS2 (CMS) exhibits excellent chiroptical and enantioselective effects, and the enantioselective properties of CMS have been studied for the treatment of neurodegenerative diseases. Intriguingly, left- and right-handed materials have different effects on promoting the differentiation of neural stem cells into neurons. However, the effect of the enantioselectivity of chiral materials on peripheral nerve regeneration remains unclear. Methods In this study, CMS@bacterial-cellulose (BC) scaffolds were fabricated using a hydrothermal approach. The CMS@BC films synthesized with L-2-amino-3-phenyl-1-propanol was defined as L-CMS. The CMS@BC films synthesized with D-2-amino-3-phenyl-1-propanol was defined as D-CMS. The biocompatibility of CMS@BC scaffolds and their effect on Schwann cells (SCs) were validated by cellular experiments. In addition, we implanted these scaffolds in rat sciatic nerve defect sites for three months. Results These chiral scaffolds display high hydrophilicity, good mechanical properties, and low cytotoxicity. Further, we found that the L-CMS scaffold was superior to the D-CMS scaffold in promoting Schwann cell (SC) proliferation. After 3 months, the scaffold showed good biocompatibility in vivo, and the nerve conducting velocities of the L-CMS and D-CMS scaffolds were 51.2 and 26.8 m/s, respectively. However, the L-CMS scaffolds showed a better regenerative effect than the D-CMS scaffolds. Similarly, the sciatic nerve function index and effects on the motor and electrophysiological functions were higher for the L-CMS than the D-CMS scaffolds. Finally, the axon diameter and myelin sheath thickness of the regenerated nerves improved in the L-CMS group. Conclusion We found that CMS can promote peripheral nerve regeneration, and in general, the L-CMS group exhibited superior repair. Overall, the findings of this study reveal that CMS can be used as a chiral nanomaterial nerve scaffolds for peripheral nerve repair.

  • Open Access

    Chiral mesostructured hydroxyapatite on 3D macroporous coralline scaffolds for enantio-selective osteogenesis

    by Chao Zhou, Anqi Liu, Ping Li, Jing Ai, Lu Han, Shaoyang Zhang, Shuai Chen, Yuanming Ouyang, Baojie Li, Shunai Che, et al.

    Chirality is ubiquitous in nature from the macroscopic to microscopic scale, and plays an important role in life.